| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |